1. GLP-1 drugs are glucagon-like peptide-1 (GLP-1) receptor agonists used for treatment of type 2 diabetes and obesity by stimulating insulin release and suppressing excess glucagon.
2. These drugs slow gastric emptying, increase the feeling of fullness, reduce appetite, and thereby contribute to weight loss in patients using them.
More Details
